Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Effects of perioperative oral care on prevention of postoperative pneumonia after lung resection: Multicenter retrospective study with propensity score matching analysis.

Iwata E, Hasegawa T, Yamada SI, Kawashita Y, Yoshimatsu M, Mizutani T, Nakahara H, Mori K, Shibuya Y, Kurita H, Komori T.

Surgery. 2019 May;165(5):1003-1007. doi: 10.1016/j.surg.2018.11.020. Epub 2019 Feb 11.

PMID:
30765141
2.

Unprecedented nucleophile-promoted 1,7-S or Se shift reactions under Pummerer reaction conditions of 4-alkenyl-3-sulfinylmethylpyrroles.

Go T, Morimatsu A, Wasada H, Tanabe G, Muraoka O, Sawada Y, Yoshimatsu M.

Beilstein J Org Chem. 2018 Oct 29;14:2722-2729. doi: 10.3762/bjoc.14.250. eCollection 2018.

3.

A retrospective study of factors associated with the development of oral candidiasis in patients receiving radiotherapy for head and neck cancer: Is topical steroid therapy a risk factor for oral candidiasis?

Kawashita Y, Funahara M, Yoshimatsu M, Nakao N, Soutome S, Saito T, Umeda M.

Medicine (Baltimore). 2018 Nov;97(44):e13073. doi: 10.1097/MD.0000000000013073.

4.

Copper-Mediated Reactions of Nitriles with Nitromethanes: Aza-Henry Reactions and Nitrile Hydrations.

Kuwabara J, Sawada Y, Yoshimatsu M.

Org Lett. 2018 Feb 16;20(4):1130-1133. doi: 10.1021/acs.orglett.8b00058. Epub 2018 Feb 7.

PMID:
29412678
5.

Cost-Effectiveness Analysis of Percutaneous Vertebroplasty for Osteoporotic Compression Fractures.

Takura T, Yoshimatsu M, Sugimori H, Takizawa K, Furumatsu Y, Ikeda H, Kato H, Ogawa Y, Hamaguchi S, Fujikawa A, Satoh T, Nakajima Y.

Clin Spine Surg. 2017 Apr;30(3):E205-E210. doi: 10.1097/BSD.0b013e3182aa4c29.

PMID:
28323701
6.

Ni-Pd Catalyzed Cyclization of Sulfanyl 1,6-Diynes: Synthesis of 1'-Homonucleoside Analogues.

Kobayashi Y, Tanahashi R, Yamaguchi Y, Hatae N, Kobayashi M, Ueno Y, Yoshimatsu M.

J Org Chem. 2017 Mar 3;82(5):2436-2449. doi: 10.1021/acs.joc.6b02841. Epub 2017 Feb 15.

PMID:
28151664
7.

Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship.

Sakamoto K, Sogabe S, Kamada Y, Sakai N, Asano K, Yoshimatsu M, Ida K, Imaeda Y, Sakamoto JI.

Biochem Biophys Res Commun. 2017 Jan 8;482(2):310-316. doi: 10.1016/j.bbrc.2016.11.060. Epub 2016 Nov 14.

PMID:
27856253
8.

Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.

Sakai E, Aoki Y, Yoshimatsu M, Nishishita K, Iwatake M, Fukuma Y, Okamoto K, Tanaka T, Tsukuba T.

Phytomedicine. 2016 Jul 15;23(8):828-37. doi: 10.1016/j.phymed.2016.04.002. Epub 2016 Apr 23.

PMID:
27288918
9.

Synthesis of Azepines via a [6 + 1] Annulation of Ynenitriles with Reformatsky Reagents.

Yoshimatsu M, Tanaka M, Fujimura Y, Ito Y, Goto Y, Kobayashi Y, Wasada H, Hatae N, Tanabe G, Muraoka O.

J Org Chem. 2015 Oct 2;80(19):9480-94. doi: 10.1021/acs.joc.5b01397. Epub 2015 Sep 30.

PMID:
26348544
10.

[Prognosis of Papillary Thyroid Carcinoma with Local Invasion].

Yamada K, Tanaka S, Hiratsuka Y, Kumabe Y, Watanabe Y, Yoshida T, Yoshimatsu M.

Nihon Jibiinkoka Gakkai Kaiho. 2015 Feb;118(2):115-22. Japanese.

PMID:
26336791
11.

IL-12 Inhibits Lipopolysaccharide Stimulated Osteoclastogenesis in Mice.

Yoshimatsu M, Kitaura H, Fujimura Y, Kohara H, Morita Y, Yoshida N.

J Immunol Res. 2015;2015:214878. doi: 10.1155/2015/214878. Epub 2015 May 3.

12.

Interventional radiology for critical hemorrhage in obstetrics: Japanese Society of Interventional Radiology (JSIR) procedural guidelines.

Sone M, Nakajima Y, Woodhams R, Shioyama Y, Tsurusaki M, Hiraki T, Yoshimatsu M, Hyodoh H, Kubo T, Takeda S, Minakami H.

Jpn J Radiol. 2015 Apr;33(4):233-40. doi: 10.1007/s11604-015-0399-0. Epub 2015 Feb 19.

PMID:
25694338
13.

Effect of cytokines on osteoclast formation and bone resorption during mechanical force loading of the periodontal membrane.

Kitaura H, Kimura K, Ishida M, Sugisawa H, Kohara H, Yoshimatsu M, Takano-Yamamoto T.

ScientificWorldJournal. 2014 Jan 19;2014:617032. doi: 10.1155/2014/617032. eCollection 2014. Review.

14.

Pharmacokinetics and safety of resveratrol derivatives in humans after oral administration of melinjo (Gnetum gnemon L.) seed extract powder.

Tani H, Hikami S, Iizuna S, Yoshimatsu M, Asama T, Ota H, Kimura Y, Tatefuji T, Hashimoto K, Higaki K.

J Agric Food Chem. 2014 Feb 26;62(8):1999-2007. doi: 10.1021/jf4048435. Epub 2014 Feb 12.

PMID:
24495149
15.

Suppression of the hypothalamic-pituitary-gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRH receptor knock-in mice.

Nakata D, Masaki T, Tanaka A, Yoshimatsu M, Akinaga Y, Asada M, Sasada R, Takeyama M, Miwa K, Watanabe T, Kusaka M.

Eur J Pharmacol. 2014 Jan 15;723:167-74. doi: 10.1016/j.ejphar.2013.12.001. Epub 2013 Dec 11.

PMID:
24333551
16.

Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells.

Shiokawa Z, Hashimoto K, Saito B, Oguro Y, Sumi H, Yabuki M, Yoshimatsu M, Kosugi Y, Debori Y, Morishita N, Dougan DR, Snell GP, Yoshida S, Ishikawa T.

Bioorg Med Chem. 2013 Dec 15;21(24):7938-54. doi: 10.1016/j.bmc.2013.09.067. Epub 2013 Oct 12.

PMID:
24169315
17.

A safe combined nephrectomy and right lobectomy using the liver hanging maneuver for huge renal cell carcinoma directly invading the right lobe of the liver: report of a case.

Yoshimatsu M, Shirabe K, Nagao Y, Harada N, Uchiyama H, Yoshizumi T, Taketomi A, Ikeda T, Tatsugami K, Maehara Y.

Surg Today. 2014 Sep;44(9):1778-82. doi: 10.1007/s00595-013-0693-3. Epub 2013 Sep 19. Review.

18.

Design, stereoselective synthesis, and biological evaluation of novel tri-cyclic compounds as inhibitor of apoptosis proteins (IAP) antagonists.

Asano M, Hashimoto K, Saito B, Shiokawa Z, Sumi H, Yabuki M, Yoshimatsu M, Aoyama K, Hamada T, Morishita N, Dougan DR, Mol CD, Yoshida S, Ishikawa T.

Bioorg Med Chem. 2013 Sep 15;21(18):5725-37. doi: 10.1016/j.bmc.2013.07.020. Epub 2013 Jul 18.

PMID:
23928071
19.

Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo.

Kitaura H, Kimura K, Ishida M, Kohara H, Yoshimatsu M, Takano-Yamamoto T.

Clin Dev Immunol. 2013;2013:181849. doi: 10.1155/2013/181849. Epub 2013 May 23. Review.

20.

Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6).

Unoki M, Masuda A, Dohmae N, Arita K, Yoshimatsu M, Iwai Y, Fukui Y, Ueda K, Hamamoto R, Shirakawa M, Sasaki H, Nakamura Y.

J Biol Chem. 2013 Mar 1;288(9):6053-62. doi: 10.1074/jbc.M112.433284. Epub 2013 Jan 9.

21.

Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimetic.

Hashimoto K, Saito B, Miyamoto N, Oguro Y, Tomita D, Shiokawa Z, Asano M, Kakei H, Taya N, Kawasaki M, Sumi H, Yabuki M, Iwai K, Yoshida S, Yoshimatsu M, Aoyama K, Kosugi Y, Kojima T, Morishita N, Dougan DR, Snell GP, Imamura S, Ishikawa T.

J Med Chem. 2013 Feb 14;56(3):1228-46. doi: 10.1021/jm301674z. Epub 2013 Jan 29.

PMID:
23298277
22.

Antitumor activity and pharmacodynamic biomarkers of a novel and orally available small-molecule antagonist of inhibitor of apoptosis proteins.

Sumi H, Yabuki M, Iwai K, Morimoto M, Hibino R, Inazuka M, Hashimoto K, Kosugi Y, Aoyama K, Yamamoto S, Yoshimatsu M, Yamasaki H, Tozawa R, Ishikawa T, Yoshida S.

Mol Cancer Ther. 2013 Feb;12(2):230-40. doi: 10.1158/1535-7163.MCT-12-0699. Epub 2012 Dec 12.

23.

Propargyl hydrazides: synthesis and conversion into pyrazoles through hydroamination.

Yoshimatsu M, Ohta K, Takahashi N.

Chemistry. 2012 Dec 3;18(49):15602-6. doi: 10.1002/chem.201202828. Epub 2012 Nov 9.

PMID:
23143924
24.

Inhibitory effect of interferon-γ on experimental tooth movement in mice.

Kohara H, Kitaura H, Yoshimatsu M, Fujimura Y, Morita Y, Eguchi T, Yoshida N.

J Interferon Cytokine Res. 2012 Sep;32(9):426-31. doi: 10.1089/jir.2011.0124.

PMID:
22963153
25.

A case of retained placenta increta successfully treated via uterine arterial embolization using N-butyl 2-cyanoacrylate.

Hamaguchi S, Okura N, Yoshimatsu M, Ogawa Y, Takizawa K, Nakajima Y.

J Minim Invasive Gynecol. 2012 Jul-Aug;19(4):527-30. doi: 10.1016/j.jmig.2012.03.020.

PMID:
22748960
26.

Inhibitory effect of gnetin C, a resveratrol dimer from melinjo (Gnetum gnemon), on tyrosinase activity and melanin biosynthesis.

Yanagihara M, Yoshimatsu M, Inoue A, Kanno T, Tatefuji T, Hashimoto K.

Biol Pharm Bull. 2012;35(6):993-6.

27.

Copper-catalyzed complete regio- and stereoselective cyclization of 1-aryl-3-sulfanyl-4-oxahepta-1,6-diynes triggered by alkynylation.

Yoshimatsu M, Sasaki H, Sugimoto Y, Nagase Y, Tanabe G, Muraoka O.

Org Lett. 2012 Jun 15;14(12):3190-3. doi: 10.1021/ol3011453. Epub 2012 Jun 6.

PMID:
22670873
28.

Granulocyte colony-stimulating-factor-producing hepatocellular carcinoma with extensive sarcomatous changes: report of a case.

Kohno M, Shirabe K, Mano Y, Muto J, Motomura T, Takeishi K, Toshima T, Yoshimatsu M, Ijichi H, Harada N, Aishima S, Uchiyama H, Yoshizumi T, Taketomi A, Maehara Y.

Surg Today. 2013 Apr;43(4):439-45. doi: 10.1007/s00595-012-0202-0. Epub 2012 May 26.

PMID:
22638568
29.

Risk factors that increase mortality after living donor liver transplantation.

Yoshizumi T, Shirabe K, Taketomi A, Uchiyama H, Harada N, Ijichi H, Yoshimatsu M, Ikegami T, Soejima Y, Maehara Y.

Transplantation. 2012 Jan 15;93(1):93-8. doi: 10.1097/TP.0b013e318238dacd.

PMID:
22203391
30.

Differences in Trocar Positioning within the Vertebral Body Using Two Different Positioning Methods: Effect on Trainee Performance.

Komemushi A, Takizawa K, Tanaka N, Yoshimatsu M, Yagihashi K, Ogawa Y, Fujikawa A, Uejima I, Koike Y, Tamura T, Takahashi M, Koizumi J, Yamakado K, Nakatsuka S, Yoshioka T, Hirota S, Nakamura K, Nakajima Y, Kuribayashi S, Kariya S, Tanigawa N, Sawada S.

Radiol Res Pract. 2011;2011:830961. doi: 10.1155/2011/830961. Epub 2011 Dec 8.

31.

Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.

Toyokawa G, Cho HS, Masuda K, Yamane Y, Yoshimatsu M, Hayami S, Takawa M, Iwai Y, Daigo Y, Tsuchiya E, Tsunoda T, Field HI, Kelly JD, Neal DE, Maehara Y, Ponder BA, Nakamura Y, Hamamoto R.

Neoplasia. 2011 Oct;13(10):887-98.

32.

Percutaneous vertebroplasty for vertebral compression fractures with intravertebral cleft: cement injection under vacuum aspiration.

Koike Y, Takizawa K, Ogawa Y, Fujikawa A, Yoshimatsu M, Nakajima Y.

J Vasc Interv Radiol. 2011 Dec;22(12):1721-6. doi: 10.1016/j.jvir.2011.08.021. Epub 2011 Oct 8.

PMID:
21983056
33.

The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6.

Toyokawa G, Cho HS, Iwai Y, Yoshimatsu M, Takawa M, Hayami S, Maejima K, Shimizu N, Tanaka H, Tsunoda T, Field HI, Kelly JD, Neal DE, Ponder BA, Maehara Y, Nakamura Y, Hamamoto R.

Cancer Prev Res (Phila). 2011 Dec;4(12):2051-61. doi: 10.1158/1940-6207.CAPR-11-0290. Epub 2011 Sep 19.

34.

Lewis acid-catalyzed propargylic etherification and sulfanylation from alcohols in MeNO₂-H₂O.

Ohta K, Koketsu E, Nagase Y, Takahashi N, Watanabe H, Yoshimatsu M.

Chem Pharm Bull (Tokyo). 2011;59(9):1133-40.

35.

Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1.

Cho HS, Kelly JD, Hayami S, Toyokawa G, Takawa M, Yoshimatsu M, Tsunoda T, Field HI, Neal DE, Ponder BA, Nakamura Y, Hamamoto R.

Neoplasia. 2011 Aug;13(8):676-84.

36.

Inhibitory effects of IL-12 on experimental tooth movement and root resorption in mice.

Yoshimatsu M, Kitaura H, Fujimura Y, Kohara H, Morita Y, Eguchi T, Yoshida N.

Arch Oral Biol. 2012 Jan;57(1):36-43. doi: 10.1016/j.archoralbio.2011.07.006. Epub 2011 Aug 6.

PMID:
21821230
37.

Discovery of 1-{4-[1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin-releasing hormone receptor.

Miwa K, Hitaka T, Imada T, Sasaki S, Yoshimatsu M, Kusaka M, Tanaka A, Nakata D, Furuya S, Endo S, Hamamura K, Kitazaki T.

J Med Chem. 2011 Jul 28;54(14):4998-5012. doi: 10.1021/jm200216q. Epub 2011 Jun 23.

PMID:
21657270
38.

Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer.

Toyokawa G, Masuda K, Daigo Y, Cho HS, Yoshimatsu M, Takawa M, Hayami S, Maejima K, Chino M, Field HI, Neal DE, Tsuchiya E, Ponder BA, Maehara Y, Nakamura Y, Hamamoto R.

Mol Cancer. 2011 May 28;10:65. doi: 10.1186/1476-4598-10-65.

39.

IL-12- and IL-18-mediated, nitric oxide-induced apoptosis in TNF-α-mediated osteoclastogenesis of bone marrow cells.

Kitaura H, Fujimura Y, Yoshimatsu M, Kohara H, Morita Y, Aonuma T, Fukumoto E, Masuyama R, Yoshida N, Takano-Yamamoto T.

Calcif Tissue Int. 2011 Jul;89(1):65-73. doi: 10.1007/s00223-011-9494-0. Epub 2011 May 25.

PMID:
21611811
40.

Clinical efficacy and value of redistributed subclavian arterial infusion chemotherapy for locally advanced breast cancer.

Shimamoto H, Takizawa K, Ogawa Y, Yoshimatsu M, Yagihashi K, Okazaki H, Kanemaki Y, Nakajima Y, Ohta T, Ogata H, Fukuda M.

Jpn J Radiol. 2011 May;29(4):236-43. doi: 10.1007/s11604-010-0547-5. Epub 2011 May 24.

PMID:
21607836
41.

Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients.

Shirabe K, Yoshimatsu M, Motomura T, Takeishi K, Toshima T, Muto J, Matono R, Taketomi A, Uchiyama H, Maehara Y.

Liver Transpl. 2011 Sep;17(9):1073-80. doi: 10.1002/lt.22324.

42.

A new method of an axial puncture approach for draining loculated pleural effusions.

Takizawa K, Nakajima Y, Ogawa Y, Hmaguchi S, Yoshimatsu M, Fujikawa A, Koike Y, Kato H.

Cardiovasc Intervent Radiol. 2011 Dec;34(6):1303-7. doi: 10.1007/s00270-011-0138-6. Epub 2011 Mar 24.

PMID:
21431973
43.

[Oncology IVR--application to palliative medicine].

Takizawa K, Ogawa Y, Yoshimatsu M, Koike Y, Hamaguchi S, Nakajima Y.

Nihon Rinsho. 2011 Feb;69(2):350-6. Review. Japanese.

PMID:
21387689
44.

IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.

Kohara H, Kitaura H, Fujimura Y, Yoshimatsu M, Morita Y, Eguchi T, Masuyama R, Yoshida N.

Immunol Lett. 2011 Jun 30;137(1-2):53-61. doi: 10.1016/j.imlet.2011.02.017. Epub 2011 Feb 19.

PMID:
21338623
45.

Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells.

Cho HS, Suzuki T, Dohmae N, Hayami S, Unoki M, Yoshimatsu M, Toyokawa G, Takawa M, Chen T, Kurash JK, Field HI, Ponder BA, Nakamura Y, Hamamoto R.

Cancer Res. 2011 Feb 1;71(3):655-60. doi: 10.1158/0008-5472.CAN-10-2446. Epub 2010 Nov 29.

46.

Transcatheter arterial chemoembolization (TACE) or embolization (TAE) for symptomatic bone metastases as a palliative treatment.

Koike Y, Takizawa K, Ogawa Y, Muto A, Yoshimatsu M, Yagihashi K, Nakajima Y.

Cardiovasc Intervent Radiol. 2011 Aug;34(4):793-801. doi: 10.1007/s00270-010-0031-8. Epub 2010 Nov 13.

PMID:
21076921
47.

Risk factors for perioperative venous thromboembolism: A retrospective study in Japanese women with gynecologic diseases.

Suzuki N, Yoshioka N, Ohara T, Yokomichi N, Nako T, Yahagi N, Igarashi S, Kobayashi Y, Yoshimatsu M, Takizawa K, Nakajima Y, Kiguchi K, Ishizuka B.

Thromb J. 2010 Nov 7;8:17. doi: 10.1186/1477-9560-8-17.

48.
49.

New cyclization of 4-oxahepta-1,6-diynes bearing sulfur and selenium functional groups.

Yoshimatsu M, Watanabe H, Koketsu E.

Org Lett. 2010 Sep 17;12(18):4192-4. doi: 10.1021/ol101540s.

PMID:
20795727
50.

Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers.

Yoshimatsu M, Toyokawa G, Hayami S, Unoki M, Tsunoda T, Field HI, Kelly JD, Neal DE, Maehara Y, Ponder BA, Nakamura Y, Hamamoto R.

Int J Cancer. 2011 Feb 1;128(3):562-73. doi: 10.1002/ijc.25366.

Supplemental Content

Loading ...
Support Center